Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Lipids Health Dis. 2018 Mar 27;17(1):59. doi: 10.1186/s12944-018-0704-x.
Hashimoto's thyroiditis is associated with serious alterations in serum lipids and glucose homeostasis. The aims of the current study were to evaluate the effect of powdered Nigella sativa on serum lipids, glucose homeostasis and anthropometric variables in patients with Hashimoto's thyroiditis.
Forty patients with Hashimoto's thyroiditis, aged between 22 and 50 years old, participated in the trial and were randomly allocated into two groups of intervention and control receiving powdered Nigella sativa or placebo daily for 8 weeks. Serum lipids, glucose homeostasis, and anthropometric variables were evaluated at baseline and after intervention.
Treatment with Nigella sativa significantly reduced body weight and body mass index (BMI). Serum concentrations of low density lipoprotein cholesterol (LDL) and triglyceride (TG) also decreased in Nigella sativa-treated group after 8 weeks; while serum high density lipoprotein cholesterol (HDL) significantly increased after treatment with Nigella sativa (P < 0.05). None of these changes had been observed in placebo treated group. Serum Nesfatin-1 concentrations was in inverse relationship with serum triglyceride (TG) (r = - 0.31, P = 0.04).
Giving attention to the potent beneficial effects of powdered black cumin seeds in improving serum lipid profile and anthropometric features in patients with Hashimoto's thyroiditis, this medicinal plant could be considered as a beneficial herbal supplement alongside with the disease- specific medications including Levothyroxine in management of Hashimoto's thyroiditis- related metabolic abnormalities.
Iranian registry of clinical trials (registration number IRCT2014090819082N2 - Registered 2014-09-29).
桥本甲状腺炎与血清脂质和葡萄糖稳态的严重改变有关。本研究的目的是评估粉末状黑种草子对桥本甲状腺炎患者血清脂质、葡萄糖稳态和人体测量学变量的影响。
40 名年龄在 22 至 50 岁之间的桥本甲状腺炎患者参与了试验,并被随机分为干预组和对照组,每天分别服用粉末状黑种草子或安慰剂 8 周。在基线和干预后评估血清脂质、葡萄糖稳态和人体测量学变量。
黑种草子治疗显著降低了体重和体重指数(BMI)。治疗 8 周后,黑种草子治疗组血清低密度脂蛋白胆固醇(LDL)和甘油三酯(TG)浓度也降低;而血清高密度脂蛋白胆固醇(HDL)在黑种草子治疗后显著增加(P<0.05)。在安慰剂治疗组未观察到这些变化。血清 Nesfatin-1 浓度与血清甘油三酯(TG)呈负相关(r=-0.31,P=0.04)。
鉴于粉末状黑种草子在改善桥本甲状腺炎患者的血清脂质谱和人体测量特征方面具有显著的有益作用,这种药用植物可以被认为是一种有益的草药补充剂,与包括左旋甲状腺素在内的针对疾病的药物一起用于管理桥本甲状腺炎相关的代谢异常。
伊朗临床试验注册中心(注册号 IRCT2014090819082N2-2014 年 9 月 29 日注册)。